id todo:paper_15164446_v24_n1_p44_Starkstein
record_format dspace
spelling todo:paper_15164446_v24_n1_p44_Starkstein2023-10-03T16:19:48Z Diagnosis, phenomenology and treatment of poststroke depression Starkstein, S.E. Lischinsky, A. Antidepressants Anxiety Depression Stroke antidepressant agent citalopram fluoxetine maprotiline mianserin nortriptyline placebo serotonin uptake inhibitor trazodone tricyclic antidepressant agent venlafaxine cerebrovascular disease clinical trial controlled clinical trial controlled study daily life activity depression disease severity double blind procedure drug efficacy drug induced disease gastrointestinal toxicity hemiplegia human insomnia major clinical study mental disease multicenter study poststroke depression randomized controlled trial rating scale review sedation seizure stroke treatment outcome Diagnosing depression in stroke patients is a challenge in neuropsychiatry since depression symptoms may overlap neurological deficit signs. The best approach is to assess the presence of depressive symptoms using semi-structured psychiatric interviews, such as the Present State Exam, the Structured Clinical Interview for DSM-IV or the Schedules for Clinical Assessment in Neuropsychiatry. The diagnosis of a depressive syndrome should be made according to standardized diagnostic criteria for mood disorders due to neurological disease such as in the DSM-IV or ICD-10. Depression rating scales such as the Hamilton Depression Scale and the Center for Epidemiologic Scales for Depression may be used to rate the depression severity and monitor the progression of antidepressant treatment. Most studies have reported the effectiveness of pharmacological treatment in patients with post-stroke depression, and there is preliminary evidence that the degree of impairment in activities od daily living (ADL) may improve as well. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_15164446_v24_n1_p44_Starkstein
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antidepressants
Anxiety
Depression
Stroke
antidepressant agent
citalopram
fluoxetine
maprotiline
mianserin
nortriptyline
placebo
serotonin uptake inhibitor
trazodone
tricyclic antidepressant agent
venlafaxine
cerebrovascular disease
clinical trial
controlled clinical trial
controlled study
daily life activity
depression
disease severity
double blind procedure
drug efficacy
drug induced disease
gastrointestinal toxicity
hemiplegia
human
insomnia
major clinical study
mental disease
multicenter study
poststroke depression
randomized controlled trial
rating scale
review
sedation
seizure
stroke
treatment outcome
spellingShingle Antidepressants
Anxiety
Depression
Stroke
antidepressant agent
citalopram
fluoxetine
maprotiline
mianserin
nortriptyline
placebo
serotonin uptake inhibitor
trazodone
tricyclic antidepressant agent
venlafaxine
cerebrovascular disease
clinical trial
controlled clinical trial
controlled study
daily life activity
depression
disease severity
double blind procedure
drug efficacy
drug induced disease
gastrointestinal toxicity
hemiplegia
human
insomnia
major clinical study
mental disease
multicenter study
poststroke depression
randomized controlled trial
rating scale
review
sedation
seizure
stroke
treatment outcome
Starkstein, S.E.
Lischinsky, A.
Diagnosis, phenomenology and treatment of poststroke depression
topic_facet Antidepressants
Anxiety
Depression
Stroke
antidepressant agent
citalopram
fluoxetine
maprotiline
mianserin
nortriptyline
placebo
serotonin uptake inhibitor
trazodone
tricyclic antidepressant agent
venlafaxine
cerebrovascular disease
clinical trial
controlled clinical trial
controlled study
daily life activity
depression
disease severity
double blind procedure
drug efficacy
drug induced disease
gastrointestinal toxicity
hemiplegia
human
insomnia
major clinical study
mental disease
multicenter study
poststroke depression
randomized controlled trial
rating scale
review
sedation
seizure
stroke
treatment outcome
description Diagnosing depression in stroke patients is a challenge in neuropsychiatry since depression symptoms may overlap neurological deficit signs. The best approach is to assess the presence of depressive symptoms using semi-structured psychiatric interviews, such as the Present State Exam, the Structured Clinical Interview for DSM-IV or the Schedules for Clinical Assessment in Neuropsychiatry. The diagnosis of a depressive syndrome should be made according to standardized diagnostic criteria for mood disorders due to neurological disease such as in the DSM-IV or ICD-10. Depression rating scales such as the Hamilton Depression Scale and the Center for Epidemiologic Scales for Depression may be used to rate the depression severity and monitor the progression of antidepressant treatment. Most studies have reported the effectiveness of pharmacological treatment in patients with post-stroke depression, and there is preliminary evidence that the degree of impairment in activities od daily living (ADL) may improve as well.
format JOUR
author Starkstein, S.E.
Lischinsky, A.
author_facet Starkstein, S.E.
Lischinsky, A.
author_sort Starkstein, S.E.
title Diagnosis, phenomenology and treatment of poststroke depression
title_short Diagnosis, phenomenology and treatment of poststroke depression
title_full Diagnosis, phenomenology and treatment of poststroke depression
title_fullStr Diagnosis, phenomenology and treatment of poststroke depression
title_full_unstemmed Diagnosis, phenomenology and treatment of poststroke depression
title_sort diagnosis, phenomenology and treatment of poststroke depression
url http://hdl.handle.net/20.500.12110/paper_15164446_v24_n1_p44_Starkstein
work_keys_str_mv AT starksteinse diagnosisphenomenologyandtreatmentofpoststrokedepression
AT lischinskya diagnosisphenomenologyandtreatmentofpoststrokedepression
_version_ 1807315289181782016